Medical Tidbits, Amgen Wins Patent Case On Repatha® (Evolocumab)

biotech news, news on clinical trials, med career newsDNA background

Proceedings on Damages and an Injunction Against Sanofi and Regeneron Will Follow

PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that a Delaware jury delivered a verdict in Amgen’s favor in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9)

Amgen brought the patent infringement action in Federal Court in Delaware against Sanofi and Regeneron Pharmaceuticals, Inc. (collectively “Defendants”). Before trial, Sanofi and Regeneron acknowledged infringement of seven patent claims in U.S. Patent Numbers 8,829,165, and 8,859,741. The trial proceeded on Defendants’ challenges to the validity of those seven claims.  The jury found that Defendants had failed to prove the patents invalid for lack of written description and enablement. Prior to the case going to the jury, the Court dismissed Defendants’ case on obviousness.  read more

Boston Scientific, Mayo Clinic Collaborate to Speed Development of Medical Devices

Small and nimble teams of Boston Scientific engineers and Mayo Clinic physicians have been working together to develop new medical technologies in areas that include interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health. The collaboration enables both parties to contribute ideas and intellectual property to solve pressing medical problems and builds upon the strengths of both parties. Mayo Clinic, which cared for 1.3 million patients in 2015, offers cutting-edge medical and surgical expertise in all disciplines, and has a long history of innovative clinical research and technology development. read more

AstraZeneca acquires all rights to Orexo´s OX-CLI project

Orexo AB (publ) today announced that AstraZeneca has decided to acquire all rights to the leukotriene C4 synthase inhibitor program (OX-CLI project) for MUSD 5. AstraZeneca established a collaboration with Orexo AB for OX-CLI in 2013 and maintained an option to acquire all rights in the program. As the program has advanced into pre-clinical development with an identified development compound (candidate drug), AstraZeneca has chosen to exercise this option. read more

Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO

Pfizer Inc. (NYSE:PFE) announced today that seven abstracts reporting on new research for tofacitinib in ulcerative colitis (UC) and Crohn’s disease will be presented at the 11th Congress of ECCO, which will be held March 16-19 in Amsterdam, The Netherlands. Among the abstracts are detailed results from two pivotal Phase 3 studies from the Oral Clinical Trials for tofAcitinib in ulceratiVE colitis (OCTAVE) program. Tofacitinib is being studied as an investigational treatment for adult patients with moderate to severe active UC. read more

MiNA Therapeutics Granted US Patent Covering Small Activating RNAs Targeting the CEBPA Gene

LONDON–(BUSINESS WIRE)–MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has granted the first in a series of patents filed by MiNA Therapeutics protecting its CEBPA drug development program (US Patent Number 9,284,553). The patent covers the company’s lead program MTL-CEBPA, currently in preclinical development for liver cancer, as well as multiple other indications. read more

Chronix Biomedical to Present Clinical Data on Its Cell-Free DNA Approach as an Early Predictor of Response to Chemotherapy at the AACR Annual Meeting

SAN JOSE, Calif. & GÖTTINGEN, Germany–(BUSINESS WIRE)–Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, today announces that it will present data relating to its cell-free DNA copy number instability (CNI) diagnostic at the American Association for Cancer Research (‘AACR’) Annual Meeting 2016 in New Orleans, Louisiana on 19 April 2016. read more

Aradigm Announces Decision for Centralized Review of Pulmaquin by the European Medicines Agency

HAYWARD, Calif.–(BUSINESS WIRE)–Aradigm Corporation (Nasdaq:ARDM) (the “Company”) today announced that the European Medicines Agency (EMA) has approved its request to review Pulmaquin®, Aradigm’s investigational inhaled liposomal ciprofloxacin product, under the Centralised Authorisation Procedure drug review process. This procedure results in a single marketing authorization that is valid in all 28 European Union countries, as well as three European Economic Area countries. Aradigm requested, and was granted, the centralized pathway on the basis that Pulmaquin represents a significant technical innovation for the potential treatment of non-cystic fibrosis bronchiectasis (non-CF BE) associated with chronic Pseudomonas aeruginosa (P. aeruginosa) infection. read more

Nautic Partners Invests in ExactCare Pharmacy

March 17, 2016 06:00 AM Eastern Daylight Time

PROVIDENCE, R.I.–(BUSINESS WIRE)–Nautic Partners, LLC today announced that it has partnered with management to invest in and recapitalize ExactCare® Pharmacy (“ExactCare”). ExactCare is a leading pharmacy focused on improving medication adherence for patients with chronic conditions and on multiple medications. ExactCare was founded by Dale Wollschleger in 2009 and is headquartered in Cleveland, OH. In connection with the Nautic investment, Doug Present, former CEO of MHA, was appointed chairman of the ExactCare board of directors and Jim Smith, former CEO of QoL meds, joined the board. read more

Zambon and US WorldMeds Partner to Bring Newron Pharmaceuticals’ Parkinson’s Disease Treatment Xadago® (safinamide) to the U.S.

MILAN–(BUSINESS WIRE)–Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, today announced a strategic agreement with US WorldMeds to commercialize Newron’s lead compound, Xadago® (safinamide), for the treatment of Parkinson’s disease in the U.S read more

 

 

Med Career News Medical Tidbits

Subscribe today for leading medical news and career advice from top medical recruiters!

 

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.